Cytokinetics, Incorporated

Cytokinetics, Incorporated financial statements

Cytokinetics, Incorporated's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 88.04M10-K
Net income−USD 784.96M10-K
Cash and equivalentsUSD 122.52M10-Q
Total debtUSD 287.56M10-Q

Cytokinetics, Incorporated financials on 6ix · Cytokinetics, Incorporated on 6ix